Skip to content
Toggle main navigation
Immunize Oregon logo
Immunize Oregon logo
  • Welcome
    • Immunize Oregon
  • Vaxx Clinic
  • Events
  • Groups
  • News
  • Opportunities
  • Lobby
    Log in
    Request to join
    Select an available language
    EN

    News

    All
    3-D printing
    Abdul Latif Jameel Poverty Action Lab (J-PAL)
    Abdul Latif Jameel Water and Food Systems Lab (J-WAFS)
    Administration
    Aeronautical and astronautical engineering
    Africa
    Agriculture
    Algorithms
    Alumni/ae
    Alzheimer's
    Anesthesia
    Anthropology
    Antibiotics
    Artificial intelligence
    Asia
    See all

    Results (13)

    MIT study finds targets for a new tuberculosis vaccine

    MIT study finds targets for a new tuberculosis vaccine

    A large-scale screen of tuberculosis proteins has revealed several possible antigens that could be developed as a new vaccine for TB, the world’s deadliest infectious disease.In the new study, a team of MIT biological engineers was able to identify a handful of immunogenic peptides, out of more than 4,000 bacterial proteins, that appear to stimulate a strong response from a type of T cells respons
    November 5, 2025
    MIT researchers develop AI tool to improve flu vaccine strain selection

    MIT researchers develop AI tool to improve flu vaccine strain selection

    Every year, global health experts are faced with a high-stakes decision: Which influenza strains should go into the next seasonal vaccine? The choice must be made months in advance, long before flu season even begins, and it can often feel like a race against the clock. If the selected strains match those that circulate, the vaccine will likely be highly effective. But if the prediction is off, pr
    August 28, 2025
    Supercharged vaccine could offer strong protection with just one dose

    Supercharged vaccine could offer strong protection with just one dose

    Researchers at MIT and the Scripps Research Institute have shown that they can generate a strong immune response to HIV with just one vaccine dose, by adding two powerful adjuvants — materials that help stimulate the immune system.In a study of mice, the researchers showed that this approach produced a much wider diversity of antibodies against an HIV antigen, compared to the vaccine given on its
    June 18, 2025
    DNA particles that mimic viruses hold promise as vaccines

    DNA particles that mimic viruses hold promise as vaccines

    Using a virus-like delivery particle made from DNA, researchers from MIT and the Ragon Institute of MGH, MIT, and Harvard have created a vaccine that can induce a strong antibody response against SARS-CoV-2.The vaccine, which has been tested in mice, consists of a DNA scaffold that carries many copies of a viral antigen. This type of vaccine, known as a particulate vaccine, mimics the structure of
    January 30, 2024
    A snapshot of cancer vaccine development

    A snapshot of cancer vaccine development

    The road to effective cancer vaccines has been long and difficult.  Although initial attempts to use a vaccine to treat cancer date back to the 1910s, the first effective therapeutic vaccine would not emerge until about a century later, when Sipuleucel-T was used to treat prostate cancer in 2010. While the FDA-approved prostate cancer vaccine generated much excitement, its success has proven diffi
    August 15, 2023
    MIT researchers to lead a new center for continuous mRNA manufacturing

    MIT researchers to lead a new center for continuous mRNA manufacturing

    A three-year research program led by faculty at MIT aims to design the world’s first fully integrated, continuous mRNA manufacturing platform, in an $82 million effort funded by the U.S. Food and Drug Administration (FDA) Center for Biologics Evaluation and Research.The resulting pilot-scale system is intended to improve society’s ability to respond to future pandemics as well as accelerate the de
    July 13, 2023
    Putting the STING into cancer immunotherapy

    Putting the STING into cancer immunotherapy

    Immune checkpoint blockade therapies have been revolutionary in the treatment of some cancer types, emerging as one of the most promising treatments for diseases such as melanoma, colon cancer, and non-small cell lung cancer.  While in some cases checkpoint blockade therapies elicit a strong immune response that clears tumors, checkpoint inhibitors do not work for all tumor types or all patients.
    May 12, 2023
    Funding to Daniel Anderson’s lab will advance research on new delivery technology for RNA vaccines and therapies

    Funding to Daniel Anderson’s lab will advance research on new delivery technology for RNA vaccines and therapies

    Sanofi will provide $25 million over five years to the lab of MIT Professor Daniel Anderson, to support the lab’s efforts to develop next-generation delivery technology for messenger RNA.Anderson, who is a professor of chemical engineering and a member of the Koch Institute for Integrative Cancer Research and the Institute for Medical Engineering and Science, and others in his lab will use the fun
    April 11, 2023
    New purification method could make protein drugs cheaper

    New purification method could make protein drugs cheaper

    One of the most expensive steps in manufacturing protein drugs such as antibodies or insulin is the purification step: isolating the protein from the bioreactor used to produce it. This step can account for up to half of the total cost of manufacturing a protein.In an effort to help reduce those costs, MIT engineers have devised a new way to perform this kind of purification. Their approach, which
    February 28, 2023
    2022-23 Takeda Fellows: Leveraging AI to positively impact human health

    2022-23 Takeda Fellows: Leveraging AI to positively impact human health

    The MIT-Takeda Program, a collaboration between MIT’s School of Engineering and Takeda Pharmaceuticals Company, fuels the development and application of artificial intelligence capabilities to benefit human health and drug development. Part of the Abdul Latif Jameel Clinic for Machine Learning in Health, the program coalesces disparate disciplines, merges theory and practical implementation, combi
    January 12, 2023
    3 Questions: Daniel Anderson on the progress of mRNA vaccines

    3 Questions: Daniel Anderson on the progress of mRNA vaccines

    Two mRNA vaccines, which received emergency authorization in late 2020, have proven critical in the fight against Covid-19. These vaccines, the first of their kind, were the culmination of decades of research on RNA. Delivered as strands of mRNA that encode a viral protein, the vaccines enter cells and begin producing proteins, allowing the immune system to recognize the virus if encountered later
    May 13, 2022
    Chronicles of the epic mission to deliver Covid vaccines to the world

    Chronicles of the epic mission to deliver Covid vaccines to the world

    The race to deliver a Covid-19 vaccine has been likened to a moonshot, but in several ways landing a man on the moon was easier. In his new book, “A Shot in the Arm: How Science, Engineering, and Supply Chains Converged to Vaccinate the World” (MIT CTL Media, 2021), MIT Professor Yossi Sheffi recounts the vaccine’s extraordinary journey from scientific breakthroughs to coronavirus antidote and mas
    October 26, 2021
    Behind Covid-19 vaccine development

    Behind Covid-19 vaccine development

    When starting a vaccine program, scientists generally have anecdotal understanding of the disease they’re aiming to target. When Covid-19 surfaced over a year ago, there were so many unknowns about the fast-moving virus that scientists had to act quickly and rely on new methods and techniques just to even begin understanding the basics of the disease.Scientists at Janssen Research & Development, d
    May 18, 2021
    Contact
    Immunize Oregon
    PO BOX 4391, Portland, Oregon 97208

    United States

    Coordinator@immunizeor.org
    Links
    • Immunize Oregon Website
    Cookies
    Reselect cookie settings
    Community engagement platform by Hivebrite.